Updated December 3, 2018

Zynerba Pharmaceuticals, Inc.

Overview: Zynerba Pharmaceuticals is a company developing cannabinoid therapies for rare and near-rare neuropsychiatric conditions. The company’s leading drug candidate is a pharmaceutical-grade transdermal...

Latest Trading

$4.26
5.45%
(+0.22)
Open 3.87
Previous Close 4.04
Today's Range
3.75 4.53
52 Week Range
3.75 16.47
Volume 899.00K
Equity Market Value $88.58M
Dividend Yield 0.00
Loading Chart...